Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-medical-pioneer-professor-siew-ng-receives-the-highest-national-engineering-honour-the-guanghua-engineering-science-and-technology-award
https://www.med.cuhk.edu.hk/press-releases/cuhk-medical-pioneer-professor-siew-ng-receives-the-highest-national-engineering-honour-the-guanghua-engineering-science-and-technology-award

CUHK medical pioneer Professor Siew Ng receives the highest national engineering honour, the Guanghua Engineering Science and Technology Award

  • The only Hong Kong scholar in medicine and health to receive the award this year
  • China’s most coveted honour in the field of engineering science and technology, commending her groundbreaking translation of gut microbiome research into life-saving clinical technologies
  • Underscoring CUHK’s leadership as a premier international hub for biomedical innovation

 

Professor Siew Ng, Croucher Professor in Medical Sciences and Professor in the Department of Medicine and Therapeutics at The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine), has been awarded the 16th Guanghua Engineering Science and Technology Award by the Chinese Academy of Engineering, in recognition of her outstanding contributions to medical research and, crucially, her pioneering work in clinical translation engineering complex gut microbiome science into scalable, life-saving healthcare solutions.

 

Presented biennially, the Guanghua Award is the highest honour in Chinese engineering science and technology. Professor Ng is the sole Hong Kong scholar in medicine and health to be honoured this year, among a select group of just 40 awardees chosen nationwide.

 

Shifting the paradigm of global public health

 

Professor Ng’s groundbreaking work has transformed the understanding of IBD across Asia. During her PhD studies at Imperial College London, she began investigating the gut microbiome and went on to lead the first large-scale epidemiological studies of IBD in Asia. Her team revealed a staggering 30-fold rise in incidence in Hong Kong over three decades, a finding that reshaped both regional and global public health perspectives. Today, Professor Ng leads a prolific international research network spanning more than 100 centres across over 30 countries and regions. ExpertScape ranks her among the top 0.029% of global experts in IBD.

 

Engineering science into life-saving medicine

 

Beyond academic discovery, Professor Ng is an innovator who bridges the gap between laboratory science and bedside care. A pioneer in clinical translation, she introduced faecal microbiota transplantation (FMT) to Hong Kong in 2013 for the treatment of life-threatening gut infections. Five years later, she established Asia’s first FMT research centre, now the sole provider of FMT services for all Hong Kong public hospitals. Her proprietary FMT MOZAICTM technology has significantly reduced hospitalisations and improved patient survival. In 2019, she established the Microbiota I-Center (MagIC) under the HKSAR Government’s InnoHK initiative and has since co-founded two biotechnology companies to translate microbiome science into accessible diagnostics and therapeutics.

 

A recipient of landmark accolades and international honours

 

A world-leading expert in the gut microbiome, Professor Ng is Associate Dean (Research) of CU Medicine and Director MagIC. She is the first Croucher Professor in Medical Sciences, a named professorship established by the Croucher Foundation. She also serves as Associate Editor of medical journal Gut, a member of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) – an elite global panel of 50 leading experts – a Foreign Member of the Academia Europaea and a Member of the Hong Kong Academy of Sciences.

 

Professor Ng has published more than 450 peer-reviewed papers in leading journals including The Lancet, Nature, Nature Genetics and Nature Medicine. Her many honours include the Ministry of Education Higher Education Outstanding Scientific Research Output Award (First Class), the Bank of China (Hong Kong) Science and Technology Innovation Prize and recognition as the first female clinician-scientist to receive the New Cornerstone Investigator award in the Chinese Mainland. She has been named a Clarivate Highly Cited Researcher and included among Stanford University’s World’s Top 2% Scientists for six consecutive years (2020-25). Her entrepreneurial achievements have earned her the Best Innopreneur Award from the Federation of Hong Kong Industries (2025) and Deloitte Hong Kong’s Technology Fast Outstanding Female Entrepreneur Award (2022).

 

A vision for Hong Kong’s biomedical future

 

On receiving the Guanghua Award, Professor Ng said: “I am deeply honoured to receive this recognition. This award belongs equally to my team and collaborators who have worked tirelessly to advance research in IBD and microbiome medicine. With Hong Kong’s growing commitment to biomedical innovation, we will continue to push boundaries and position the city as a leading international hub for life sciences and health technology.”

 

Professor Siew Ng

Professor Siew Ng

 

More Press Releases

CU Medicine reveals the interplay between epigenetic changes and gut microbiome in newborns

CU Medicine reveals the interplay between epigenetic changes and gut microbiome in newborns

Research
CU Medicine launches the “Women in Science and Medicine Academy”  to attract 100 female talents Leveraging Hong Kong’s institutional strengths to become a regional hub for women medical scientists

CU Medicine launches the “Women in Science and Medicine Academy”  to attract 100 female talents Leveraging Hong Kong’s institutional strengths to become a regional hub for women medical scientists

Milestone
CU Medicine pioneers synbiotics to alleviate children’s anxiety and sensory sensitivity symptoms

CU Medicine pioneers synbiotics to alleviate children’s anxiety and sensory sensitivity symptoms

Research
CUHK study shows 1 in 1,000 Hong Kong people will have inflammatory bowel disease in the next decade Annual healthcare costs will exceed HK$400 million by 2034

CUHK study shows 1 in 1,000 Hong Kong people will have inflammatory bowel disease in the next decade Annual healthcare costs will exceed HK$400 million by 2034

Research
A global study led by CUHK and the University of Calgary charts four-stage evolution of Inflammatory Bowel Disease

A global study led by CUHK and the University of Calgary charts four-stage evolution of Inflammatory Bowel Disease

Research
CUHK study finds vigorous disinfection linked to increased risk of eczema and atopic diseases

CUHK study finds vigorous disinfection linked to increased risk of eczema and atopic diseases

Research
CU Medicine develops the Metagenome-Assembled Genome Inventory for Children (MAGIC) to promote early-life microbiome research

CU Medicine develops the Metagenome-Assembled Genome Inventory for Children (MAGIC) to promote early-life microbiome research

Research
CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms

CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms

Research
CU Medicine’s large-scale mother-baby study finds altered gut microbiome  in pregnant mothers with gestational diabetes mellitus affects infants’ neurodevelopment

CU Medicine’s large-scale mother-baby study finds altered gut microbiome in pregnant mothers with gestational diabetes mellitus affects infants’ neurodevelopment

Research
CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders  Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms

Research
CUHK Professor Siew Ng is the first female clinician-scientist in mainland China selected as a New Cornerstone Investigator; New Cornerstone Science Laboratory inaugurated to dissect diet-microbiome interactions to improve human health

CUHK Professor Siew Ng is the first female clinician-scientist in mainland China selected as a New Cornerstone Investigator; New Cornerstone Science Laboratory inaugurated to dissect diet-microbiome interactions to improve human health

Awards and honors
Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Two CU Medicine scholars are elected as Foreign Members of the Academia Europaea

Awards and honors
CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong  to be selected as a New Cornerstone Investigator

CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong to be selected as a New Cornerstone Investigator

Awards and honors
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

Research
CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

Research
Inaugural Croucher Professorship in Medical Sciences lecture by Professor Siew Ng:   A Magical Pursuit

Inaugural Croucher Professorship in Medical Sciences lecture by Professor Siew Ng: A Magical Pursuit

Awards and honors
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.